{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:37:22Z","timestamp":1787312242952,"version":"build-2736575974"},"reference-count":77,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["CDR J.0019.18 and MIS F.4512.20"],"award-info":[{"award-number":["CDR J.0019.18 and MIS F.4512.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Bile acids exert diverse actions on host metabolism and immunity through bile acid-activated receptors, including Takeda G protein-coupled receptor 5 (TGR5). We have recently evidenced an alteration in bile acids in cancer cachexia, an inflammatory and metabolic syndrome contributing to cancer death. This current study aims to further explore the links emerging between bile acids and cancer cachexia. First, we showed that bile flow is reduced in cachectic mice. Next, comparing mice inoculated with cachexia-inducing and with non-cachexia-inducing C26 colon carcinoma cells, we demonstrated that alterations in the bile acid pathways and profile are directly associated with cachexia. Finally, we performed an interventional study using ursodeoxycholic acid (UDCA), a compound commonly used in hepatobiliary disorders, to induce bile acid secretion and decrease inflammation. We found that UDCA does not improve hepatic inflammation and worsens muscle atrophy in cachectic mice. This exacerbation of the cachectic phenotype upon UDCA was accompanied by a decreased TGR5 activity, suggesting that TGR5 agonists, known to reduce inflammation in several pathological conditions, could potentially counteract cachectic features. This work brings to light major evidence sustaining the emerging links between bile acids and cancer cachexia and reinforces the interest in studying bile acid-activated receptors in this context.<\/jats:p>","DOI":"10.3390\/cancers13246389","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T04:23:47Z","timestamp":1640060627000},"page":"6389","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice"],"prefix":"10.3390","volume":"13","author":[{"given":"Morgane M.","family":"Thibaut","sequence":"first","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Gillard","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"},{"name":"Laboratory of Hepato-Gastroenterology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Dolly","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8915-795X","authenticated-orcid":false,"given":"Martin","family":"Roumain","sequence":"additional","affiliation":[{"name":"Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle A.","family":"Leclercq","sequence":"additional","affiliation":[{"name":"Laboratory of Hepato-Gastroenterology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-6082","authenticated-orcid":false,"given":"Nathalie M.","family":"Delzenne","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-9259","authenticated-orcid":false,"given":"Giulio G.","family":"Muccioli","sequence":"additional","affiliation":[{"name":"Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-3234","authenticated-orcid":false,"given":"Laure B.","family":"Bindels","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/jcsm.12633","article-title":"Cancer cachexia and skeletal muscle atrophy in clinical studies: What do we really know?","volume":"11","author":"Dolly","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e47258","DOI":"10.15252\/embr.201847258","article-title":"Energy metabolism in cachexia","volume":"20","author":"Rohm","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","article-title":"Cancer Cachexia: More than skeletal muscle wasting","volume":"4","author":"Schmidt","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argiles","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: Frequent, costly, and deadly","volume":"4","author":"Farkas","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: Facts and numbers update 2016","volume":"7","author":"Anker","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: Microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Sayin","year":"2016","journal-title":"Cell Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Tailleux","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2019_238","article-title":"The pharmacology of bile acids and their receptors","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_17","first-page":"19","article-title":"Bile acid-activated receptors: GPBAR1 (TGR5) and other G protein-coupled receptors","volume":"256","author":"Keitel","year":"2019","journal-title":"Transgenic Models Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits Atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"ref_21","first-page":"484","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_22","first-page":"1","article-title":"TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue","volume":"9","author":"Perino","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","article-title":"The bile acid chenodeoxycholic acid increases human brown adipose tissue activity","volume":"22","author":"Broeders","year":"2015","journal-title":"Cell Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tem.2012.10.006","article-title":"Cancer cachexia: Malignant inflammation, tumorkines, and metabolic mayhem","volume":"24","author":"Tsoli","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1440-1746.1999.01982.x","article-title":"Inflammation-induced cholestasis","volume":"14","author":"Trauner","year":"1999","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2741\/3400","article-title":"Nuclear receptors: Mediators and modifiers of inflammation-induced cholestasis","volume":"14","author":"Mulder","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcsm.12652","article-title":"Inflammation-induced cholestasis in cancer cachexia","volume":"12","author":"Thibaut","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Schwarz, S., Prokopchuk, O., Esefeld, K., Gr\u00f6schel, S., Bachmann, J., Lorenzen, S., Friess, H., Halle, M., and Martignoni, M.E. (2017). The clinical picture of cachexia: A mosaic of different parameters (experience of 503 patients). BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3116-9"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.020","article-title":"Primary biliary cholangitis: Old and novel therapy","volume":"47","author":"Floreani","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00535-020-01681-z","article-title":"Emerging therapies in primary sclerosing cholangitis: Pathophysiological basis and clinical opportunities","volume":"55","author":"Vesterhus","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bonetto, A., Rupert, J.E., Barreto, R., and Zimmers, T.A. (2016). The Colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia. J. Vis. Exp., e54893.","DOI":"10.3791\/54893"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ballar\u00f2, R., Lopalco, P., Audrito, V., Beltr\u00e0, M., Pin, F., Angelini, R., Costelli, P., Corcelli, A., Bonetto, A., and Szeto, H. (2021). Targeting Mitochondria by SS-31 Ameliorates the whole body energy status in cancer- and chemotherapy-induced cachexia. Cancers, 13.","DOI":"10.3390\/cancers13040850"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Massart, I.S., Paulissen, G., Loumaye, A., Lause, P., P\u00f6tgens, S.A., Thibaut, M.M., Balan, E., Deldicque, L., Atfi, A., and Louis, E. (2020). Marked increased production of acute phase reactants by skeletal muscle during cancer cachexia. Cancers, 12.","DOI":"10.3390\/cancers12113221"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2014.10.011","article-title":"Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration","volume":"477","author":"Charola","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: From basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19694","DOI":"10.1038\/srep19694","article-title":"Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma","volume":"6","author":"Mutemberezi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acs.jproteome.5b00981","article-title":"Accounting for the multiple natures of missing values in label-free quantitative proteomics data sets to compare imputation strategies","volume":"15","author":"Lazar","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14728222.2016.1103735","article-title":"Therapeutic targets for cholestatic liver injury","volume":"20","author":"Woolbright","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1074\/jbc.RA118.002733","article-title":"The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice","volume":"293","author":"Sasaki","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jth.13612","article-title":"Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent","volume":"15","author":"Reddel","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2015","journal-title":"ISME J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bindels, L.B., Neyrinck, A.M., Salazar, N., Taminiau, B., Druart, C., Muccioli, G.G., Fran\u00e7ois, E., Blecker, C., Richel, A., and Daube, G. (2015). Non digestible Oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131009"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3748\/wjg.v27.i22.3010","article-title":"Role of bile acids in liver diseases mediated by the gut microbiome","volume":"27","author":"Shao","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"101077","DOI":"10.1016\/j.eucr.2019.101077","article-title":"Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer\u2019s syndrome","volume":"29","author":"Zarrabi","year":"2019","journal-title":"Urol. Case Rep."},{"key":"ref_50","first-page":"53","article-title":"Paraneoplastic cholestasis associated with prostate carcinoma","volume":"15","author":"Koruk","year":"2004","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3816\/CLM.2006.n.044","article-title":"Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin\u2019s Lymphoma","volume":"7","author":"Barta","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42ii","DOI":"10.1136\/gut.52.suppl_2.ii42","article-title":"Cholestasis","volume":"52","author":"Elferink","year":"2003","journal-title":"Gut"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3748\/wjg.14.5641","article-title":"Physiology of bile secretion","volume":"14","author":"Esteller","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/mp060011k","article-title":"Methods to evaluate biliary excretion of drugs in humans: An updated review","volume":"3","author":"Ghibellini","year":"2006","journal-title":"Mol. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00002018-200629060-00004","article-title":"Dose adaptation of antineoplastic drugs in patients with liver disease","volume":"29","author":"Tchambaz","year":"2006","journal-title":"Drug Saf."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/gast.2001.26262","article-title":"Tauroursodesoxycholate-induced choleresis involves p38MAPK activation and translocation of the bile salt export pump in rats","volume":"121","author":"Kurz","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","article-title":"Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis","volume":"124","author":"Kurz","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C\u2013dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/gut.2007.140871","article-title":"Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC -\/PKA-dependent mechanism in rat liver","volume":"57","author":"Wimmer","year":"2008","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hep.23625","article-title":"Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver","volume":"52","author":"Cruz","year":"2010","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and Ursodeoxycholic Acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107396","DOI":"10.1016\/j.pharmthera.2019.107396","article-title":"Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy","volume":"203","author":"Goossens","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct\u2013ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2013.01.026","article-title":"Differential effects of norUDCA and UDCA in obstructive cholestasis in mice","volume":"58","author":"Fickert","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest. Endosc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2018-316801","article-title":"Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis","volume":"68","author":"Rupp","year":"2019","journal-title":"Gut"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through Inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI76289","article-title":"TGR5 reduces macrophage migration through mTOR-induced C\/EBP\u03b2 differential translation","volume":"124","author":"Perino","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1074\/jbc.M112.446575","article-title":"Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease","volume":"288","author":"McMahan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000450917","article-title":"Role of the G protein-coupled bile acid receptor TGR5 in liver damage","volume":"35","author":"Reich","year":"2017","journal-title":"Dig. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-011-0044-4","article-title":"Ursodeoxycholic acid treatment in a rat model of cancer cachexia","volume":"3","author":"Tschirner","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jcp.29839","article-title":"Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor","volume":"236","author":"Abrigo","year":"2021","journal-title":"J. Cell. Physiol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/24\/6389\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:00Z","timestamp":1760169000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/24\/6389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":77,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["cancers13246389"],"URL":"https:\/\/doi.org\/10.3390\/cancers13246389","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}